- Report
- February 2022
- 77 Pages
Global
From €2200EUR$2,450USD£1,873GBP
- Report
- June 2019
- 248 Pages
Global
From €2469EUR$2,750USD£2,103GBP
- Report
- January 2022
- 194 Pages
Global
From €1975EUR$2,200USD£1,682GBP
- Report
- September 2023
- 215 Pages
Global
From €3749EUR$4,175USD£3,192GBP
- Report
- June 2022
- 216 Pages
Global
From €3749EUR$4,175USD£3,192GBP
- Report
- February 2024
- 104 Pages
Europe
From €2649EUR$2,950USD£2,256GBP
- Report
- November 2023
- 101 Pages
Asia Pacific
From €1100EUR$1,225USD£937GBP
€2200EUR$2,450USD£1,873GBP
- Report
- January 2024
- 120 Pages
Global
From €5342EUR$5,950USD£4,549GBP
- Report
- July 2023
- 111 Pages
Global
From €4040EUR$4,500USD£3,441GBP
- Report
- July 2021
- 255 Pages
Global
From €4443EUR$4,949USD£3,784GBP
- Report
- March 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- March 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- May 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- May 2024
- 200 Pages
Global
From €3726EUR$4,150USD£3,173GBP
- Report
- March 2023
- 141 Pages
Global
From €3231EUR$3,599USD£2,752GBP
- Report
- June 2024
- 108 Pages
Europe
From €3098EUR$3,450USD£2,638GBP
- Report
- June 2024
- 106 Pages
Asia Pacific
From €3098EUR$3,450USD£2,638GBP
- Report
- November 2023
- 182 Pages
Global
From €3995EUR$4,450USD£3,402GBP
- Report
- February 2024
- 150 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €2671EUR$2,975USD£2,275GBP
€3142EUR$3,500USD£2,676GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more